Clinical Trials
5 trialsNCT06551142 2026-05-22
PanTumor-101
GlaxoSmithKline
Phase 1 Recruiting
NCT05303532 2026-05-19
ROSY-D
AstraZeneca
Phase 3 Enrolling by invitation
NCT03907475 2026-05-13
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT03842228 2026-04-29
COD
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT06031233 2026-03-30
MINUTE
Isala
Phase 4 Recruiting